image438
image439

Targeted cancer surgery

Targeted cancer surgeryTargeted cancer surgeryTargeted cancer surgery

Targeted cancer surgery

Targeted cancer surgeryTargeted cancer surgeryTargeted cancer surgery

Transforming the efficacy of robot-assisted cancer surgery

Lightpoint Medical is a technology leader in precision-guided robotic cancer surgery. We are developing miniaturized imaging and sensing tools for advanced intra-operative cancer detection. Our mission is to improve the lives of people with cancer by transforming the efficacy of robotic surgery. 

SEE OUR PRODUCTS

Optimizing surgical performance

image440

Over recent decades, robots have transformed cancer surgery. However, in spite of the technological advances in robotic platforms, surgeons still remain completely dependent on their sight to detect cancer intra-operatively. As a result, surgeons often leave cancer behind or remove more healthy tissue than needed. Residual disease increases the need for further drug treatment, radiotherapy, and surgery. Similarly, removing healthy, functional tissue increases post-surgical complications and escalates healthcare costs.

image441

At Lightpoint, we are optimizing the performance of robotic cancer surgery, by developing miniaturized imaging and sensing tools to accurately detect cancer intra-operatively during robot-assisted surgery. The aims of the tools are to aid surgical decision making, improve patient outcomes and save costs for healthcare system. 

Enhancing surgical precision

Lightpoint has two miniaturized robotic probes in development. The technologies incorporate recent advances in miniaturized sensors and detect cancer-targeted drugs already validated for whole-body imaging, such as SPECT/PET scans. The miniaturized probes aim to accurately identify cancer, enabling the full removal of diseased tissue, or confirm its absence, helping to preserve healthy, functional tissue. SENSEI® is our first robotic probe. Find out more in the video below.

image442

Find out more about our robotic gamma probe, SENSEI®

See our SENSEI® product website

News highlights

Lightpoint receives CE Mark for SENSEI®

Lightpoint receives CE Mark for SENSEI®

Lightpoint receives CE Mark for SENSEI®

  SENSEI®, Lightpoint's miniaturized probe designed for intra-operative detection of sentinel lymph nodes as well as cancer metastasis through the lymphatic system, has received regulatory approval in the EU.

Find out more

SENSEI® authorized for sale in the US

Lightpoint receives CE Mark for SENSEI®

Lightpoint receives CE Mark for SENSEI®

SENSEI®, our miniaturized probe for minimally-invasive and robot-assisted cancer surgery, has been successfully registered with the FDA and is now authorized for sale in the US. 

Find out more

Hospital del Mar, Barcelona, initiate clinical trial with SENSEI®

Hospital del Mar, Barcelona, initiate clinical trial with SENSEI®

Hospital del Mar, Barcelona, initiate clinical trial with SENSEI®

Dr Lluis Fumado and the team at Hospital del Mar, Barcelona, is the first to initiate in a multi-center clinical trial with SENSEI® in prostate cancer surgery.

Find out more

Lightpoint secures first distribution deal for SENSEI®

Hospital del Mar, Barcelona, initiate clinical trial with SENSEI®

Hospital del Mar, Barcelona, initiate clinical trial with SENSEI®

TECNASA, Technologias Asociadas will be responsible for the distribution and sale of SENSEI® in Spain and Portugal. 

Visit TECHNASA's website

Management team

image443

Dr David Tuch, CEO & Founder

Simon McCoy, Finance Director

Dr David Tuch, CEO & Founder

David has more than a decade of experience in the medical imaging and pharmaceutical  sectors. Previously, he was Head of Research Alliances at GE Healthcare and Head of Clinical Imaging at Novartis. Before joining industry, David served on the faculty of Harvard Medical School and Massachusetts General Hospital, Department of Radiology. He holds a PhD from MIT and Harvard Medical School, and a BA from the University of Chicago. 

image444

Claire Woodthorpe, COO

Simon McCoy, Finance Director

Dr David Tuch, CEO & Founder

 Claire is responsible for the day-to-day management of Lightpoint. She has more than ten years of experience in commercial operations, including six years in the medical device industry. Before joining Lightpoint she held board level positions in technology companies specializing in  research and development. Claire is a CTA-qualified  accountant. She holds an LLB with Honors in Law with Accounting and Finance from the University of Liverpool. 

image445

Simon McCoy, Finance Director

Simon McCoy, Finance Director

Stewart Forbes, Head of Engineering

 Simon heads up Lightpoint's finance team. He has 30 years’ experience in blue chip international organizations in the life science, healthcare, and leisure sectors. As  an experienced finance leader, his diverse experience includes business strategy, business analytics, pricing, M&A activity, process  improvement and streamlining, and financial management. Simon has a BA  with Honors in Geography from the University of Exeter. 

image446

Stewart Forbes, Head of Engineering

Stewart Forbes, Head of Engineering

Stewart Forbes, Head of Engineering

Stewart heads Lightpoint's in-house engineering team, which includes electronics, mechanical and software engineering. The team develops Lightpoint's products from concept to regulatory-approved medical devices. Stewart is an electronics engineer with over 20 years of experience in managing engineering teams.

image447

Tony Muller, Head of Operations

Stewart Forbes, Head of Engineering

Klaas Klooster, Head of Clinical

 Tony is responsible for Lightpoint's regulatory and quality teams, as well as operational project management. He has over 30 years of experience in product development, project management and quality systems. Tony has held senior positions with blue chip companies such as GE, Unilever, the BBC.

image448

Klaas Klooster, Head of Clinical

Stewart Forbes, Head of Engineering

Klaas Klooster, Head of Clinical

 Klaas manages all of Lightpoint's multi-center clinical studies and supports clinicans running their own independent studies with our technologies. He has been managing clinical research for medical device companies for over two decades, including senior clinical positions at Stryker, Wright Medical and DePuy Synthes.  

image449

Kevin Nolan, Head of Commercial Operations

Kevin Nolan, Head of Commercial Operations

Kevin Nolan, Head of Commercial Operations

 Kevin manages Lightpoint's global network of sales distributors, as well as adding commercial insight into new product development. He has over 20 years of experience in medical device business development, sales and world-wide distribution managment. Kevin has also, over many years, consulted with numerous early-stage life science companies to support product launches, determine regulatory and reimbursement strategies; and provide price analysis/positioning. 

image450

Jo O'Shea, Head of Communications

Kevin Nolan, Head of Commercial Operations

Kevin Nolan, Head of Commercial Operations

 Jo is responsible for Lightpoint's external communication, as well as marketing and grant management. She has secured in excess of £8M in new non-dilutive funding for Lightpoint's R&D and clinical activities. Previous to Lightpoint she worked for over a decade in the not-for-profit sector, securing large-scale funding for charitable projects. Jo holds a BA with Honours in International History & Politics and an MPhil in Russian & East European Studies from Oxford University.  

image451

Kunal Vyas, Head of Research

Kevin Nolan, Head of Commercial Operations

Kunal Vyas, Head of Research

Kunal is responsible for Lightpoint's early-stage research before it transitions to the engineering team for formal product development. He is creating a pipeline of highly innovative  technologies for intra-operative cancer detection across a wide range of major cancer indications. Kunal has almost a decade of experience in technical R&D in imaging and advanced sensors for medical devices. He holds a PhD in Experimental Physics from the University of Cambridge.

Board of directors

image452

Dr David Tuch, Chairman & CEO

Dr David Tuch, Chairman & CEO

Dr David Tuch, Chairman & CEO

image453

David Ford, MBA

Dr David Tuch, Chairman & CEO

Dr David Tuch, Chairman & CEO

David has more than 20 years experience in the medical device industry. Formerly the Executive Director  of BSI Group, he was responsible for the worldwide Healthcare and  Testing activity for the British Standards Institution. David is currently CEO at Ingenica Solutions and a Non-Executive Director at NHS TrusTECH. David has represented the United Kingdom at the World Health Organization, the FDA and the European Commission in developing policy for medical devices and medical device regulation. David was trained at  St. Mary’s Hospital Medical School, London and at Brunel University, and  holds an MBA from INSEAD. 

image454

Nadim Yared

Dr David Tuch, Chairman & CEO

Elizabeth Usher, MBA

 Nadim is the President and Chief Executive Officer of CVRx. He has previously served as Vice President and General Manager of  Medtronic Navigation, the leading global supplier of integrated image-guided surgery products. He also worked at GE Medical for 10-years, where he was Vice President of Global  Marketing for the OEC Medical Systems and Vice President and General  Manager of GE’s European X-ray business based in Paris. Nadim has an  engineering degree from Ecole Nationale Supérieure des  Télécommunications, and an MBA from INSEAD, France. 

image455

Elizabeth Usher, MBA

Elizabeth Usher, MBA

Elizabeth Usher, MBA

Elizabeth has more than 20 years of experience in the medical device industry. She is currently the Executive Director & CEO of  the American Academy of Dermatology (AAD), and was previously the Chief Marketing, Sales, and Communications Officer for the College of American Pathologists (CAP). Prior to joining CAP, she held executive leadership positions at GE Healthcare and Amersham Health. She has an MBA in International Business from Thunderbird School of Global Management and a Bachelor of Science degree from Georgia  Institute of Technology. 

image456

Martin Jamieson

Elizabeth Usher, MBA

Martin Jamieson

After completing his early career in the pharmaceutical industry at Wyeth and 3M,  Martin worked for Smiths Medical. Over 16 years he took on increasingly senior Managing Director roles, finally as Managing Director Smiths Medical International. Latterly, Martin has served as CEO of Rayner Surgical and CEO & Chairman of Nextism Plc, a medical device company focused on improving  rehabilitation for stroke patients using non-invasive brain stimulation. Martin currently works with a number of private equity houses and is a Non-Executive Director of a large NHS Foundation Trust Hospital and  multiple medtech SMEs. 

Our investors and partners

Work with us to transform cancer surgery

 At Lightpoint we're building a world-class team to transform the practice of cancer surgery. We hire trailblazing professionals who want  to make a meaningful impact. We offer excellent benefits and perks. Come join us. 

See current opportunites

Regulatory documents

ISO 13485 Certificate for Lightpoint Medical (pdf)Download
SENSEI CE Mark Certificate (pdf)Download

Contact us

Direct email contacts

General questions: info@lightpointmedcial.com 

Sales: sales@lightpointmedical.com

Service: service@lightpointmedical.com

For Lightpoint's privacy policy related to contacting us and data protection, please refer to the PRIVACY POLICY link below.

Offices

 Lightpoint Medical, Ltd
Misbourne Works
Waterside, Chesham
HP5 1PE, United Kingdom
Phone: +44 (0)1494 917 697

 Lightpoint Medical, Inc.
Regus Harvard Square
One Mifflin Place, Suite 400
Cambridge, Massachusetts
02138, USA
Phone: +1 844 311 7083

 Lightpoint Medical B.V.
Joop Geesinkweg 901-999
Amsterdam-Duivendrecht
1114 AB, Netherlands
Phone: +31 20 561-6094

Connect with us

Copyright © 2021 Lightpoint Medical - All Rights Reserved.

  • Privacy Policy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept